• Tags: glaucoma
Eyes On Glaucoma 2025 highlights advancements in disease care
Events

Eyes On Glaucoma 2025 highlights advancements in disease care

Largest virtual glaucoma meeting of the year sees record attendance.
Surprising protective role of estrogen may lower glaucoma risk in women
Research

Surprising protective role of estrogen may lower glaucoma risk in women

Age at menopause had a significant effect on RNFL thickness among women.
Qlaris Bio developing fixed-dose latanoprost and QLS-111 eye drop for glaucoma
Pipeline

Qlaris Bio developing fixed-dose latanoprost and QLS-111 eye drop for glaucoma

New combination therapy involving the prostaglandin analog targets lowering episcleral venous pressure to lower IOP.
SpyGlass Pharma raises $75M to advance sustained-release drug delivery platform
Pipeline

SpyGlass Pharma raises $75M to advance sustained-release drug delivery platform

Financing to support upcoming phase 3 trials on the company’s long-term delivery system of bimatoprost for glaucoma and OHT treatment.
Five-year data supports iStent inject as safe and effective
Research

Five-year data supports iStent inject as safe and effective

Study finds 72% medication reduction after iStent inject implantation from baseline to last follow-up.
Air pollution exposure leading to more ocular disease cases among adults
Research

Air pollution exposure leading to more ocular disease cases among adults

Myopic eyes demonstrated increased risk of ocular disease with exposure to air pollution.
Nicox releases favorable phase 3b data on IOP-lowering glaucoma therapeutic
Pipeline

Nicox releases favorable phase 3b data on IOP-lowering glaucoma therapeutic

Exploratory Whistler trial reports statistically significant IOP lowering and uveoscleral outflow for NCX 470, an NO-donating bimatoprost formulation.
New World Medical launches upgraded Streamline Surgical System
Products

New World Medical launches upgraded Streamline Surgical System

Single-use, implant-free device offers surgeons improved visualization of key anatomical structures via a new transparent tip.
SpyGlass Pharma reports positive 18-month data on glaucoma sustained delivery system
Research

SpyGlass Pharma reports positive 18-month data on glaucoma sustained delivery system

Presented at ASCRS, new findings show promising visual outcomes and IOP lowering following sustained-release delivery of bimatoprost.
Clinical outcomes support JJV's violet-filtering IOL for glaucoma
Research

Clinical outcomes support JJV's violet-filtering IOL for glaucoma

New research on the Tecnis Symfony OptiBlue IOL shows promising visual outcomes just one week after implantation post-cataract surgery.
Sight Sciences debuts OMNI Edge Surgical System
Products

Sight Sciences debuts OMNI Edge Surgical System

Launching during ASCRS, this new hand-held and single-use MIGS device features the company’s patented, higher-capacity viscoelastic delivery TruSync technology.
Registration is now open for Eyes On Glaucoma 2025
Events

Registration is now open for Eyes On Glaucoma 2025

Largest virtual glaucoma-focused event of the year highlights the latest advancements in disease care and offers up to 4.5 hours of COPE-accredited CE.
FDA clears BVI's laser endoscopic ophthalmic system
Products

FDA clears BVI's laser endoscopic ophthalmic system

Set to debut at AAO later this year, Leos will launch as the only next-gen laser system that lowers IOP by addressing aqueous humor production in a minimally invasive ab interno procedure.
Are uveitis patients at an increased risk for complications post-cataract surgery?
Research

Are uveitis patients at an increased risk for complications post-cataract surgery?

Postoperative complications varied based on the uveitis subtype.
 Avisi reports positive 6-month data on VisiPlate aqueous shunt for glaucoma
Pipeline

Avisi reports positive 6-month data on VisiPlate aqueous shunt for glaucoma

MIBS device composed of non-fibrotic nanotechnology-based metamaterials lowered OAG patients’ mean IOP by 40%.
Lifestyle habits may benefit cognitive impairment in glaucoma
Research

Lifestyle habits may benefit cognitive impairment in glaucoma

Mindfulness meditation may help slow the rate of neurocognitive decline.
Eyenovia proposes merger with Betaliq to form glaucoma company
Business

Eyenovia proposes merger with Betaliq to form glaucoma company

Potential deal would result in a new glaucoma-focused company combining the EyeSol water-free drug delivery tech and Optejet device platform.
Iantrek reports favorable 2-year data on uveoscleral outflow technology for glaucoma
Research

Iantrek reports favorable 2-year data on uveoscleral outflow technology for glaucoma

New study details favorable safety profile of the CycloPen System as a bio-interventional platform for OAG patients undergoing combined cataract surgery.
Glaukos and RadiusXR partner with Topcon on VF testing platform
Products

Glaukos and RadiusXR partner with Topcon on VF testing platform

Collaboration involves the launch of RadiusXR’s new wearable vision testing platform, the first tech of its kind to combine visual fields correlated to the clinical standard.
Nationwide survey links regular drinking with POAG
Research

Nationwide survey links regular drinking with POAG

Four or more drinks per week associated with an increased risk of primary open-angle glaucoma.